Published in

Wiley, Alimentary Pharmacology and Therapeutics, 4(47), p. 540-541

DOI: 10.1111/apt.14486

Links

Tools

Export citation

Search in Google Scholar

Editorial: tofacitinib and biologics for moderate-to-severe ulcerative colitis-what is best in class? Authors’ reply

Journal article published in 2018 by S. Bonovas ORCID, T. Lytras, G. Nikolopoulos, L. Peyrin-Biroulet ORCID, S. Danese ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO